Barbara Biere

Barbara Biere

Auto-generated profile, based on publicly available information

Barbara Biere

Unit 17, Influenza and Other Respiratory Viruses, Department of Infectious Diseases, National Influenza Centre Robert Koch Institute Berlin Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
BBBarbara Biere
Barbara Biere
BBBettina Bauer
Bettina Bauer
BSBrunhilde Schweiger
Brunhilde Schweiger
Since the 1970s, influenza B viruses have diverged into two antigenically distinct virus lineages called the Yamagata and Victoria lineages. We present the first real-time PCR assay for virus lineage differentiation to supplement classical antigenic analyses. The assay was successfully applied to 310 primary samples collected in Germany from 2007 to 2009.

1 April 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMartin Schulze
Martin Schulze
ANAndreas Nitsche
Andreas Nitsche
BSBrunhilde Schweiger
Brunhilde Schweiger
BBBarbara Biere
Barbara Biere
The current spread of pandemic influenza A(H1N1)v virus necessitates an intensified surveillance of influenza virus infections worldwide. So far, in many laboratories routine diagnostics were limited to generic influenza virus detection only. To provide interested laboratories with real-time PCR assays for type and subtype identification, we present a bundle of PCR assays with which any human influenza A and B virus can be easily identified, including assays for the detection of the pandemic A(H1N1)v virus. The assays show optimal performance characteristics in their validation on plasmids containing the respective assay target sequences. All assays have furthermore been applied to several thousand clinical samples since 2007 (assays for seasonal influenza) and April 2009 (pandemic influenza assays), respectively, and showed excellent results also on clinical material. We consider the presented assays to be well suited for the detection and subtyping of circulating influenza viruses.

28 March 2024 in Eurosurveillance
Verified
Journal Article
Open access
WCWei Cai
Wei Cai
SKSophie Köndgen
Sophie Köndgen
KTKristin Tolksdorf
Kristin Tolksdorf
RDRalf Dürrwald
Ralf Dürrwald
ESEkkehard Schuler
Ekkehard Schuler
JRJanine Reiche
Janine Reiche
Background: Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. Aim: To describe, for children aged < 5 years, the 2021 and 2022/23 RSV seasons in Germany. Methods: Through data and 16,754 specimens from outpatient sentinel surveillance, we investigated RSV seasonality, circulating lineages, and affected children’s age distributions in 2021 and 2022/23. Available information about disease severity from hospital surveillance was analysed for patients with RSV-specific diagnosis codes (n = 13,104). Differences between RSV seasons were assessed by chi-squared test and age distributions trends by Mann–Kendall test. Results: RSV seasonality was irregular in 2021 (weeks 35–50) and 2022/23 (weeks 41–3) compared to pre-COVID-19 2011/12–2019/20 seasons (median weeks 51–12). RSV positivity rates (RSV-PR) were higher in 2021 (40% (522/1,291); p < 0.001) and 2022/23 (30% (299/990); p = 0.005) than in prior seasons (26% (1,430/5,511)). Known globally circulating RSV-A (lineages GA2.3.5 and GA2.3.6b) and RSV-B (lineage GB5.0.5a) strains, respectively, dominated in 2021 and 2022/23. In 2021, RSV-PRs were similar in 1 – < 2, 2 – < 3, 3 – < 4, and 4 – < 5-year-olds. RSV hospitalisation incidence in 2021 (1,114/100,000, p < 0.001) and in 2022/23 (1,034/100,000, p < 0.001) was approximately double that of previous seasons’ average (2014/15–2019/20: 584/100,000). In 2022/23, proportions of RSV patients admitted to intensive care units rose (8.5% (206/2,413)) relative to pre-COVID-19 seasons (6.8% (551/8,114); p = 0.004), as did those needing ventilator support (6.1% (146/2,413) vs 3.8% (310/8,114); p < 0.001). Conclusions: High RSV-infection risk in 2–4-year-olds in 2021 and increased disease severity in 2022/23 possibly result from lower baseline population immunity, after NPIs diminished exposure to RSV.

1 April 2010 in Journal of Clinical Virology
Verified
Journal Article
Closed access
BBBarbara Biere
Barbara Biere
BSBrunhilde Schweiger
Brunhilde Schweiger

29 April 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
WCWei Cai
Wei Cai
RDRalf Dürrwald
Ralf Dürrwald
BBBarbara Biere
Barbara Biere
BSBrunhilde Schweiger
Brunhilde Schweiger
WHWalter Haas
Walter Haas
JRJanine Reiche
Janine Reiche
Based on our national outpatient sentinel surveillance, we have developed a novel approach to determine respiratory syncytial virus (RSV) epidemic seasons in Germany by using RSV positivity rate and its lower limit of 95% confidence interval. This method was evaluated retrospectively on nine RSV seasons, and it is also well‐suited to describe off‐season circulation of RSV in near real time as observed for seasons 2020/21 and 2021/22 during the COVID‐19 pandemic. Prospective application is of crucial importance to enable timely actions for health service delivery and prevention.

14 July 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
DODjin-Ye Oh
Djin-Ye Oh
BBBarbara Biere
Barbara Biere
MGMarkus Grenz
Markus Grenz
TWThorsten Wolff
Thorsten Wolff
BSBrunhilde Schweiger
Brunhilde Schweiger
JRJanine Reiche
Janine Reiche
Human parainfluenza viruses (HPIVs) are important causes of respiratory illness, especially in young children. However, surveillance for HPIV is rarely performed continuously, and national-level epidemiologic and genetic data are scarce. Within the German sentinel system, to monitor acute respiratory infections (ARI), 4463 respiratory specimens collected from outpatients < 5 years of age between October 2015 and September 2019 were retrospectively screened for HPIV 1–4 using real-time PCR. HPIV was identified in 459 (10%) samples. HPIV-3 was the most common HPIV-type, with 234 detections, followed by HPIV-1 (113), HPIV-4 (61), and HPIV-2 (49). HPIV-3 was more frequently associated with age < 2 years, and HPIV-4 was more frequently associated with pneumonia compared to other HPIV types. HPIV circulation displayed distinct seasonal patterns, which appeared to vary by type. Phylogenetic characterization clustered HPIV-1 in Clades 2 and 3. Reclassification was performed for HPIV-2, provisionally assigning two distinct HPIV-2 groups and six clades, with German HPIV-2s clustering in Clade 2.4. HPIV-3 clustered in C1, C3, C5, and, interestingly, in A. HPIV-4 clustered in Clades 2.1 and 2.2. The results of this study may serve to inform future approaches to diagnose and prevent HPIV infections, which contribute substantially to ARI in young children in Germany.